Pay-to-Participate Trials and Vulnerabilities in Research Ethics Oversight
This Viewpoint discusses ethical considerations surrounding randomized clinical trials (RCTs) funded by patients who pay to enroll in them, and gaps in IRB oversight that could allow the trials to be approved despite possible patient exploitation and questionable scientific quality and social value.
Gespeichert in:
Veröffentlicht in: | JAMA : the journal of the American Medical Association 2019-10, Vol.322 (16), p.1553-1554 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This Viewpoint discusses ethical considerations surrounding randomized clinical trials (RCTs) funded by patients who pay to enroll in them, and gaps in IRB oversight that could allow the trials to be approved despite possible patient exploitation and questionable scientific quality and social value. |
---|---|
ISSN: | 0098-7484 1538-3598 |
DOI: | 10.1001/jama.2019.14703 |